| Index hospitalization before sOATa | Day 1 | Day 2 | Day 3 |
---|---|---|---|---|
Short-Acting opioids | Median (IQR) MME per 24Â h | Median (IQR) MME per 24Â h | Median (IQR) MME per 24Â h | Median (IQR) MME per 24Â h |
   All short-acting opioids | 29 (3, 74) | 200 (135, 303) | 276 (180, 466) | 320 (135, 400) |
 | Cases administered (%) | Cases administered (%) | Cases administered (%) | Cases administered (%) |
   Oxycodone IR | 8 (34.8) | 14 (60.9) | 14 (60.9) | 14 (60.9) |
   Oxycodone ER | 0 (0.0) | 2 (8.7) | 0 (0) | 1 (4.3) |
   Hydromorphone PO | 5 (21.7) | 9 (39.1) | 8 (34.8) | 6 (26.1) |
   Hydromorphone IV | 5 (21.7) | 9 (39.1) | 6 (26.1) | 2 (8.7) |
   Other short-acting opioidsb | 2 (8.7) | 1 (4.3) | 1 (4.3) | 1 (4.3) |
Medications for OUD | Cases administered (%) | Cases administered (%) | Cases administered (%) | Cases administered (%) |
   Buprenorphine | 1 (4.3) | 1 (4.3) | 1 (4.3) | 1 (4.3) |
   Methadone | 13 (56.5) | 15 (65.2) | 15 (65.2) | 15 (65.2) |
Non-Opioid adjuvants | Cases administered (%) | Cases administered (%) | Cases administered (%) | Cases administered (%) |
   Opioid withdrawalc | 9 (39.1) | 13 (56.5) | 14 (60.9) | 14 (60.9) |
   Gabapentinoids | 8 (34.8) | 13 (56.5) | 14 (60.9) | 14 (60.9) |
   Benzodiazepines | 7 (30.4) | 9 (39.1) | 9 (39.1) | 8 (34.8) |
   Barbiturates | 1 (4.3) | 1 (4.3) | 1 (4.3) | 1 (4.3) |
   Non-benzodiazepine anxiolyticsd | 4 (17.4) | 4 (17.4) | 4 (17.4) | 4 (17.4) |
   Anti-spasmodics | 6 (26.1) | 13 (56.5) | 11 (47.8) | 11 (47.8) |
   NSAIDs or acetaminophen | 20 (87.0) | 19 (82.6) | 19 (82.6) | 20 (87.0) |
Safety | No. (%) | No. (%) | No. (%) | No. (%) |
Naloxone administrations | 0 (0) | 1 (4.3) | 0 (0) | 0 (0) |
Sedation (RASSe ≤ − 3 or POSS‡ ≥ 3) | 0 (0) | 0 (0.0) | 0 (0.0) | 1 (4.3) |
Falls | 0 (0) | 0 (0) | 0 (0) | 0 (0) |